Lonza Group AG (OTCMKTS:LZAGY – Get Free Report) saw a large increase in short interest in June. As of June 15th, there was short interest totalling 52,400 shares, an increase of 4,663.6% from the May 31st total of 1,100 shares. Based on an average daily volume of 71,700 shares, the short-interest ratio is presently 0.7 days.
Wall Street Analysts Forecast Growth
Separately, Berenberg Bank upgraded shares of Lonza Group to a “strong-buy” rating in a research note on Sunday, June 23rd.
Check Out Our Latest Research Report on Lonza Group
Lonza Group Stock Up 0.5 %
Lonza Group Cuts Dividend
The firm also recently declared a dividend, which was paid on Wednesday, May 29th. Stockholders of record on Thursday, May 16th were issued a dividend of $0.0995 per share. The ex-dividend date of this dividend was Wednesday, May 15th.
Lonza Group Company Profile
Lonza Group AG, together with its subsidiaries, supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe and internationally. It operates through Biologics, Small Molecules, Cell & Gene, and Capsules & Health Ingredients segments. The Biologics segment engages in the contract development and manufacturing of biopharmaceuticals for clinical and commercial manufacturing needs throughout the product lifecycle, including drug substance and drug product manufacturing.
Featured Articles
- Five stocks we like better than Lonza Group
- Manufacturing Stocks Investing
- What’s Behind Walgreens Stock Plunge: What Investors Can Do Next
- CD Calculator: Certificate of Deposit Calculator
- MarketBeat Week in Review – 6/24 – 6/28
- Insider Selling Explained: Can it Inform Your Investing Choices?
- General Mills Stock Drops After Revenue Miss in Fiscal Q4 2024
Receive News & Ratings for Lonza Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lonza Group and related companies with MarketBeat.com's FREE daily email newsletter.